A novel predictor in patients undergoing heart valve surgery: systemic inflammation response index: a single center cross-sectional study
dc.contributor.author | Karacalilar, M. | |
dc.contributor.author | Demir, M. | |
dc.date.accessioned | 2024-04-24T17:33:11Z | |
dc.date.available | 2024-04-24T17:33:11Z | |
dc.date.issued | 2023 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | OBJECTIVE: Inflammation plays a pivotal role in heart valve disease (HVD). This study aimed at evaluating the prognostic value of systemic inflammation response index (SIRI) after valve replacement surgery.SUBJECTS AND METHODS: The study en-rolled 90 patients who underwent valve replace-ment surgery. SIRI was calculated using labo-ratory data on admission. Receiver operating characteristic (ROC) analysis was used to calcu-late the optimal cutoff values of SIRI for predict-ing mortality. Univariable and multivariable COX analysis was used to assess the relationship of SIRI with clinical outcomes.RESULTS: 5-year mortality rate was high-er in SIRI >= 1.55 group than SIRI <1.55 group [16 (38.1%) vs. 9 (18.8%)]. In receiver operating char-acteristic analysis, the optimal cutoff values for SIRI were 1.55 (area under the curve 0.654, p: 0.025). Univariable analysis revealed that SIRI [OR: 1.41, 95%CI (1.13-1.75), p<0.001] was an in-dependent predictor of 5-years mortality. Multi -variable analysis revealed that glomerular filtra-tion rate (GFR) [OR: 0.98, 95%CI (0.97-0.99)] was an independent predictor of 5-years mortality.CONCLUSIONS: Although SIRI is a preferable parameter for the detection of long-term mortali-ty, it failed to predict in-hospital and 1-year mor-tality. Larger multi-center studies are needed to investigate effect of SIRI on prognosis. | en_US |
dc.identifier.endpage | 1022 | en_US |
dc.identifier.issn | 1128-3602 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 36808347 | |
dc.identifier.scopus | 2-s2.0-85148678353 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 1016 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/20510 | |
dc.identifier.volume | 27 | en_US |
dc.identifier.wos | WOS:000951507500023 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Verduci Publisher | en_US |
dc.relation.ispartof | European Review For Medical and Pharmacological Sciences | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cardiac Valve Prostheses | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Heart Valve Prosthesis Implantation | en_US |
dc.title | A novel predictor in patients undergoing heart valve surgery: systemic inflammation response index: a single center cross-sectional study | en_US |
dc.title | A novel predictor in patients undergoing heart valve surgery: systemic inflammation response index: a single center cross-sectional study | |
dc.type | Article | en_US |